Buyun Ma
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
The biological process of lysine-tRNA charging is therapeutically targetable in liver cancer.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 04, 2020
Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.
Journal: Cellular and molecular gastroenterology and hepatology
Published: March 15, 2020
Mitochondrial Fusion Via OPA1 and MFN1 Supports Liver Tumor Cell Metabolism and Growth.
Journal: Cells
Published: December 20, 2019
Suppression of Hepatocellular Carcinoma by Mycophenolic Acid in Experimental Models and in Patients.
Suppression of Hepatocellular Carcinoma by Mycophenolic Acid in Experimental Models and in Patients.
Journal: Transplantation
Published: February 13, 2019
LGR5 marks targetable tumor-initiating cells in mouse liver cancer.
Journal: Nature communications
Published: January 24, 2019
Sofosbuvir directly promotes the clonogenic capability of human hepatocellular carcinoma cells.
Journal: Clinics and research in hepatology and gastroenterology
Published: November 20, 2018
Direct-acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta-analysis.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: September 13, 2018
Dichotomal functions of phosphorylated and unphosphorylated STAT1 in hepatocellular carcinoma.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: June 17, 2018
Nitazoxanide Inhibits Human Norovirus Replication and Synergizes with Ribavirin by Activation of Cellular Antiviral Response.
Journal: Antimicrobial agents and chemotherapy
Published: April 09, 2018
Last Updated: 09/26/2026